Cargando…

High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma

INTRODUCTION: Lung adenocarcinoma (LUAD) is the most common type of lung cancer. DEP domain-containing 1 B (DEPDC1B) is involved in the development of several cancers; however, its role in LUAD is unknown. Therefore, we aimed to determine the biological function and prognostic value of DEPDC1B in LU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Pulin, Chen, Xiaojuan, Zhou, Sijing, Xia, Xingyuan, Wang, Enze, Han, Rui, Zeng, Daxiong, Fei, Guanghe, Wang, Ran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332445/ https://www.ncbi.nlm.nih.gov/pubmed/35912402 http://dx.doi.org/10.2147/JIR.S369219

Ejemplares similares

Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysis
por: Wang, Enze, et al.
Publicado: (2022)

Mortality and risk factors for COVID-19 in hemodialysis patients: A systematic review and meta-analysis
por: Li, Pulin, et al.
Publicado: (2022)

High Expression of PSRC1 Predicts Poor Prognosis in Lung Adenocarcinoma
por: Han, Rui, et al.
Publicado: (2023)

Effect of Methylation Status of lncRNA-MALAT1 and MicroRNA-146a on Pulmonary Function and Expression Level of COX2 in Patients With Chronic Obstructive Pulmonary Disease
por: Sun, Li, et al.
Publicado: (2021)

Efficacy and Safety of Nanoadministration in the Treatment of Non-Small-Cell Lung Cancer Is Good to Some Extent: A Systematic Review and Meta-Analysis
por: Han, Rui, et al.
Publicado: (2022)

The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
por: Sun, Peng, et al.
Publicado: (2022)

Molecular regulation and therapeutic implications of cell death in pulmonary hypertension
por: Wang, Enze, et al.
Publicado: (2023)

DEPDC1 up‐regulates RAS expression to inhibit autophagy in lung adenocarcinoma cells
por: Wang, Wei, et al.
Publicado: (2020)

AB079. Upregulation of DEPDC1B correlates with tumor progression and predicts a poor prognosis in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2017)

ARL14 as a Prognostic Biomarker in Non-Small Cell Lung Cancer
por: Zhang, Binbin, et al.
Publicado: (2021)

Integrated analysis of the molecular mechanisms in idiopathic pulmonary fibrosis
por: Zhu, Ke, et al.
Publicado: (2021)

Microbiota Imbalance Contributes to COPD Deterioration by Enhancing IL-17a Production via miR-122 and miR-30a
por: Zhu, Ke, et al.
Publicado: (2020)

Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis
por: Jiang, Huihui, et al.
Publicado: (2021)

Correction to: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis
por: Jiang, Huihui, et al.
Publicado: (2021)

Knockdown of DEPDC1B inhibits the development of glioblastoma
por: Chen, Xu, et al.
Publicado: (2020)

High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer
por: Zhao, Huishan, et al.
Publicado: (2019)

Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary disease
por: Wang, Ran, et al.
Publicado: (2015)

DEPDC1B collaborates with GABRD to regulate ESCC progression
por: Yuan, Yunfeng, et al.
Publicado: (2022)

DEPDC1B promotes migration and invasion in pancreatic ductal adenocarcinoma by activating the Akt/GSK3β/Snail pathway
por: Liu, Xu, et al.
Publicado: (2020)

PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
por: Tang, Suping, et al.
Publicado: (2022)

Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma
por: Deng, Jun, et al.
Publicado: (2022)

Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1
por: Dang, Xiao-Wei, et al.
Publicado: (2021)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis
por: Liu, Changmin, et al.
Publicado: (2020)

Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma
por: Liu, Xin, et al.
Publicado: (2022)

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
por: Li, Chong, et al.
Publicado: (2015)

Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma
por: Zhao, Cui-Cui, et al.
Publicado: (2018)

CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma
por: Sun, Longhua, et al.
Publicado: (2015)

High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma
por: Xu, Zhangyan, et al.
Publicado: (2020)

AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma
por: Zhang, Shusen, et al.
Publicado: (2020)

DEPDC1B is a key regulator of myoblast proliferation in mouse and man
por: Figeac, Nicolas, et al.
Publicado: (2019)

MicroRNA-26b attenuates monocrotaline-induced pulmonary vascular remodeling via targeting connective tissue growth factor (CTGF) and cyclin D1 (CCND1)
por: Wang, Ran, et al.
Publicado: (2016)

Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma
por: Fan, Xiaoyan, et al.
Publicado: (2022)

GEMIN6 Overexpression Correlates with the Low Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma
por: Peng, Yunsong, et al.
Publicado: (2022)

Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
por: Tian, Chuan, et al.
Publicado: (2021)

DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma
por: Zhou, Chao, et al.
Publicado: (2019)

[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma
por: Zhao, Cui-Cui, et al.
Publicado: (2023)

SKA3 Up-regulation Promotes Lung Adenocarcinoma Growth and is a Predictor of Poor Prognosis
por: Sun, Rong-Li, et al.
Publicado: (2019)

Getting Sucker Punched by Depdc5 Really Hurts
por: Weston, Matthew
Publicado: (2020)

High SNRPA1 expression leads to poor prognosis in patients with lung adenocarcinoma
por: Yang, Juan Juan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5iqqeq6m7ng3omt2pn3bi5nur3